Inhibition of HER2 tyrosine kinase disrupts androgen-receptor functioning

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2005年 / 2卷 / 6期
关键词：
D O I：
10.1038/ncpuro0192
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：264 / 265
页数：1
相关论文
共 50 条
  • [41] Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer
    Yang, Xue
    Wu, Dapeng
    Yuan, Shengli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [42] Tyrosine kinase inhibitors (TKIs) enhance response to HER2 targeted antibodies
    Ivers, L.
    Collins, D.
    Canonici, A.
    Gullo, G.
    O'Donovan, N.
    Crown, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S40 - S40
  • [43] Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
    Contessa, Joseph N.
    Bhojani, Mahaveer S.
    Freeze, Hudson H.
    Rehemtulla, Alnawaz
    Lawrence, Theodore S.
    CANCER RESEARCH, 2008, 68 (10) : 3803 - 3809
  • [44] HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
    Mellinghoff, IK
    Vivanco, I
    Kwon, A
    Tran, C
    Wongvipat, J
    Sawyers, CL
    CANCER CELL, 2004, 6 (05) : 517 - 527
  • [45] Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
    B N Rexer
    A-J L Ham
    C Rinehart
    S Hill
    N de Matos Granja-Ingram
    A M González-Angulo
    G B Mills
    B Dave
    J C Chang
    D C Liebler
    C L Arteaga
    Oncogene, 2011, 30 : 4163 - 4174
  • [46] Concurrent HER2 vaccination and inhibition of kinase activity: safety and immunogenicity
    Albrecht, Huguette
    IMMUNOTHERAPY, 2012, 4 (07) : 671 - 674
  • [47] Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
    Rexer, B. N.
    Ham, A-J L.
    Rinehart, C.
    Hill, S.
    Granja-Ingram, N. de Matos
    Gonzalez-Angulo, A. M.
    Mills, G. B.
    Dave, B.
    Chang, J. C.
    Liebler, D. C.
    Arteaga, C. L.
    ONCOGENE, 2011, 30 (40) : 4163 - 4174
  • [48] Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
    Kim, Hwang-Phill
    Yoon, Young-Kwang
    Kim, Jin-Won
    Han, Sae-Won
    Hur, Hyung-Seok
    Park, Jinah
    Lee, Ju-Hee
    Oh, Do-Youn
    Im, Seock-Ah
    Bang, Yung-Jue
    Kim, Tae-You
    PLOS ONE, 2009, 4 (06):
  • [49] Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/β-catenin signaling in HER2 overexpressing human breast cancer cells
    Wang, Ke
    Ma, Qingyong
    Ren, Yu
    He, Jianjun
    Zhang, Yong
    Zhang, Yunfeng
    Chen, Wuke
    ONCOLOGY REPORTS, 2007, 17 (01) : 89 - 96
  • [50] Targeting multiple pathways in breast cancer: Androgen receptor, HER2, and mTOR
    Gordon, Michael A.
    D'Amato, Nicholas
    Gu, Haihua
    Wong, Darren
    Elias, Anthony
    Richer, Jennifer K.
    CANCER RESEARCH, 2015, 75
12345